CV Sciences 将于 11 月 13 日报告 2025 年第三季度业绩，并主持网络直播和电话访问电话会议。 CV Sciences to report Q3 2025 results Nov. 13, hosting a call with webcast and phone access.

CV科学将在2025年11月13日市场关闭后发布其2025年第三季度的财政结果,并于下午1时30分在PT(下午4时30分)主办一次电话会议。 CV Sciences will release its third-quarter 2025 financial results after the market close on November 13, 2025, and host a conference call at 1:30 p.m. PT (4:30 p.m. 同一天,可进行现场网播和电话访问。 ET) the same day, with a live webcast and phone access available. 该公司是一家以大麻提取物和植物产品为主的消费者健康公司,其品牌+Plus CBDTM在临床研究和自我确认的GRAS地位的支持下,作为自然产品市场上最畅销的大麻提取产品推销。 The company, a consumer wellness firm focused on hemp extracts and plant-based products, markets its +PlusCBD™ brand as the top-selling hemp-extract product in the natural products market, backed by clinical research and self-affirmed GRAS status. 它还在+PlusHLTHTM下提供无大麻素补充品,并通过在欧盟和选定国际市场分发的 " 文化食品 " 提供植物食品补充品。 It also offers cannabinoid-free supplements under +PlusHLTH™ and plant-based foods through Cultured Foods™, distributed in the EU and select international markets. 该公司在圣地亚哥,大连和华沙经营设施,并拥有补充剂制造商Elevated Softgels. The company operates facilities in San Diego, Grand Junction, and Warsaw, and owns Elevated Softgels, a supplement manufacturer. 前瞻性说明面临风险和不确定性。 Forward-looking statements are subject to risks and uncertainties.